Reprogramming the immune system for tolerance with monoclonal antibodies

Area of Science:

• Immunology
• Transplantation Biology
• Autoimmunity

Background:

• Monoclonal antibodies targeting CD4, CD8, and CD11a can modulate T cell function in vivo.
• T cell depletion or blockade can create an environment permissive to immune tolerance.

Purpose of the Study:

• To investigate the induction of specific immune tolerance using monoclonal antibodies.
• To explore the potential of 'reprogramming' T cells to control immune responses.

Main Methods:

• Administered short courses of non-depleting CD4 and CD8 antibodies to induce tolerance to foreign antigens (immunoglobulins, bone marrow, skin grafts).
• Utilized combinations of depleting and blockading CD4 and CD8 antibodies for tolerance induction to MHC and minor antigens.
• Analyzed T cell anergy as a mechanism of induced tolerance.

Main Results:

• Achieved tolerance to minor transplantation antigens without T cell depletion, even in sensitized mice.
• Induced tolerance to MHC and minor antigens via skin grafts using combined antibody strategies.
• Demonstrated antigen-specific tolerance, with T cells exhibiting an anergic state.

Conclusions:

• Peripheral induction of tolerant, anergic T cells explains key features of immune tolerance.
• This 'reprogramming' strategy offers precise control over T cell tolerance in vivo.
• Clinical application demonstrated in treating a patient with autoimmune vasculitis.